Breaking 15:00 Ukraine: Deadly Russian Attack Destroys Residential Building in Kyiv Region 14:30 COP31: Countries Reject Climate Deal Over Fossil Fuels as Summit Ends in Deadlock 14:00 Short Stature Football World Cup: Morocco Opens Campaign With 2-0 Victory Over Guatemala 13:30 United States: Trump Reacts to Reported FBI Database Hack Amid Growing Cybersecurity Concerns 13:06 France: Confidential Email Found at Home of Marine Le Pen Ally Deepens Investigation Into Suspected Leaks to RN 13:00 Morocco: 2030 World Cup Investments Raise Concerns Over Small Business Exclusion 12:45 Spain Election 2026: Pedro Sánchez Faces Political Challenge as Conservative Opposition Gains Ground 12:30 Morocco-Lebanon Relations: His Majesty King Mohammed VI Reaffirms Commitment to Strengthening Bilateral Ties 12:15 Morocco: Drone Component Exports Surge 60%, According to EBRD Report 12:00 U17 World Cup 2026: Morocco Face China in Crucial Clash to Secure Round of 32 Qualification 11:45 Signal: Mobile Screenshot Restrictions Introduced Amid Growing AI Surveillance Threats 11:30 London: Islamophobia Conference Sparks Controversy Over Former Iranian Revolutionary Guard Commander's Participation 11:15 Israel: Eisenkot and Netanyahu’s Parties Resume Coalition Talks Amid Deep Political Divisions 11:00 North Korea: Kim Jong Un Ignores Trump as US Efforts to Restart Diplomatic Talks Fail 10:45 United States: Democrats Plan Sanctions Against West Bank Violence Upon Returning to Power 10:30 Israel: Ultra-Orthodox Parties Await Revised Military Draft Proposal From Gadi Eisenkot 10:15 Morocco: NARSA Steps Up Inspections of Driving Schools Over Unregulated Training Prices 10:00 Gaza: Peace Board Threatens to Hand Responsibility Back to UN Amid Disputes With Israel 09:45 Normandy Train Derailment: SNCF Defends Employees as Investigation Raises Safety Concerns 09:30 South Korea: Education Minister Resigns After AI Cheating Scandal Rocks University Entrance Exams 09:15 COP31: Fossil Fuel Dispute Threatens Global Climate Agreement 09:00 Nvidia: US Accounting Investigation Adds to Growing Pressure on Chip Giant 08:45 Morocco: Dirham Depreciates 0.6% Against the Euro and 1.7% Against the US Dollar 01:00 Jeff Goldblum in Marrakech: Hollywood Actor Receives Golden Star and Thanks His Majesty King Mohammed VI at FIFM 2026 00:15 Marrakech Film Festival 2026: Prince Moulay Rachid Presides Over Royal Opening Dinner 23:00 Daniel Ek Backs Europa Fusion: AI Meets the Race for Clean Nuclear Energy 22:30 Alaska: Your Next Governor Is a Wikipedia Nerd 22:00 Bending Spoons Acquires Mailchimp for $3.68 Billion: A Major Shift in the Global Technology Market 21:30 Nvidia: Jensen Huang Scandal Deepens as AI Industry Faces Growing Uncertainty 21:00 Dakhla: Morocco Launches African Network to Combat Child Soldier Recruitment and Support Reintegration 20:30 United States: Aviation Authorities Issue Security Alert Over Al-Qaeda Supporters' Calls to Replicate Flydubai Incident 20:00 Peru: Powerful 6.7-Magnitude Earthquake Strikes Central Region, Residents Evacuate Buildings 19:00 Spain: Rue20 Condemns Exclusion of Moroccan Journalist at People's Party Event in Malaga 18:30 Israel: Avigdor Lieberman Proposes Alliance With Ultra-Orthodox Parties to Oust Netanyahu 18:00 Hip-Hop and UNESCO: A Global Campaign for International Cultural Recognition 17:30 Morocco: Four Key Positions Secured in CAF Permanent Committees 17:00 United States: Bayer Secures Major Settlement in Long-Running Roundup Cancer Dispute 16:30 South Africa: Women Demand Urgent Government Action Against Gender-Based Violence and Femicide 16:00 France: Court Recognizes Racist Motive in Michel Zecler Assault, Sentences Three Police Officers 15:30 Morocco: Butchers Required to Display Red Meat Prices and Declare Product Origins

New study shows promising results for J&J prostate cancer treatment

Sunday 31 May 2026 - 13:58
New study shows promising results for J&J prostate cancer treatment

A new clinical study has revealed encouraging results for patients with high-risk prostate cancer, showing that a treatment regimen developed by Johnson & Johnson may significantly improve outcomes and reduce the risk of disease progression.

The findings were presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago. Researchers reported that the drug Erleada, when combined with hormone-blocking therapy before and after prostate surgery, improved the likelihood of eliminating cancer cells and lowered the risk of cancer spread or death.

According to the study, patients who received the combination treatment were substantially more likely to have little or no detectable cancer in the prostate at the time of surgery compared with those who received hormone therapy alone. Researchers noted that the difference was particularly significant among individuals diagnosed with high-risk localized or locally advanced prostate cancer.

The trial followed participants for more than five years, allowing scientists to evaluate the long-term effectiveness of the treatment strategy. Results indicated that the combination therapy reduced the risk of disease recurrence, progression, or death, offering new hope for patients facing aggressive forms of the disease.

Medical experts attending the conference described the findings as potentially transformative for prostate cancer care. Current treatment standards for high-risk patients generally include surgery to remove the prostate, often combined with radiation therapy. The new data suggest that introducing advanced drug therapy before and after surgery may further improve patient outcomes.

Researchers also evaluated an extended treatment approach involving a full year of therapy surrounding surgery. The results support the growing interest in using targeted treatments earlier in the disease process to increase the chances of long-term cancer control.

Prostate cancer remains one of the most frequently diagnosed cancers among men worldwide. Health specialists emphasize that continued advances in research, early detection, and innovative therapies are essential for improving survival rates and quality of life for patients.

The study's findings are expected to contribute to ongoing discussions among regulatory authorities and healthcare professionals regarding future treatment options for high-risk prostate cancer patients.


  • Fajr
  • Sunrise
  • Dhuhr
  • Asr
  • Maghrib
  • Isha

Read more

This website, walaw.press, uses cookies to provide you with a good browsing experience and to continuously improve our services. By continuing to browse this site, you agree to the use of these cookies.